Amlodipine plus atorvastatin is cost-effective compared to atenolol plus atorvastatin, amlodipine or atenolol alone: The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

被引：0
|
作者：
Lindgren, P. [1 ]
Buxton, M. [2 ]
Kahan, T. [3 ]
Poulter, N. [4 ]
Dahlof, B. [5 ]
Sever, P. S. [3 ]
Wedel, H. [6 ]
Jonsson, B. [7 ]
机构：
[1] European Hlth Econ, Stockholm, Sweden
[2] Brunel Univ, Uxbridge UB8 3PH, Middx, England
[3] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden
[4] Univ London Imperial Coll Sci Technol & Med, London, England
[5] Sahlgrens Univ Hosp, Gothenburg, Sweden
[6] Nord Sch Publ Hlth, Gothenburg, Sweden
[7] Stockholm Sch Econ, S-11383 Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：857 / 857
页数：1
相关论文
共 34 条
  • [21] Economic evaluation of the anglo-Scandinavian cardiac outcomes trial (ASCOT)-blood pressure lowering arm (BPLA):: A sub-study on incremental cost-effectiveness of amlodipine-based regimen vs. atenolol-based regimen in primary prevention among hypertensive patients with additional risk factors
    Lindgren, Peter
    Tang, Simon
    Buxton, Martin
    Kahan, Thomas
    Poulter, Neil
    Dahlof, Bjorn
    Sever, Peter
    Wedel, Hans
    Buch, Jan
    Jonsson, Bengt
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 392A - 392A
  • [22] Long-term treatment with atorvastatin does not improve diastolic function compared with placebo in hypertensive patients in the Anglo Scandinavian Cardiac Outcome Trial (ASCOT)
    Thompson, David
    Hughes, Alun
    Mayet, Jamil
    Stanton, Alice
    Thom, Simon
    JOURNAL OF HUMAN HYPERTENSION, 2016, 30 (10) : 646 - 646
  • [23] Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes -: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA) -: Response to Tseng
    Poulter, NR
    Sever, PS
    Dahlöf, B
    Wedel, H
    DIABETES CARE, 2005, 28 (10) : 2595 - 2596
  • [24] Impact of atorvastatin on cardiovascular events in 2440 men and women aged 65 years and above: Evidence from the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA)
    Poulter, NR
    Dahlof, B
    Sever, PS
    Wedel, H
    Collier, D
    STROKE, 2006, 37 (02) : 695 - 695
  • [25] Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial
    Sever, Peter S.
    Poulter, Neil R.
    Chang, Choon L.
    Hingorani, Aroon
    Thom, Simon A.
    Hughes, Alun D.
    Welsh, Paul
    Sattar, Naveed
    EUROPEAN HEART JOURNAL, 2012, 33 (04) : 486 - 494
  • [26] Health economics of prevention of coronary heart disease and vascular events:: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Jönsson, B
    Buxton, M
    Hertzman, P
    Kahan, T
    Poulter, N
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (Suppl 1) : S53 - S56
  • [27] Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
    B Jönsson
    M Buxton
    P Hertzman
    T Kahan
    N Poulter
    Journal of Human Hypertension, 2001, 15 : S53 - S56
  • [28] Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial
    Peter S Sever
    Björn Dahlöf
    Neil R Poulter
    Hans Wedel
    Gareth Beevers
    Mark Caulfield
    Rory Collins
    Sverre E Kjeldsen
    Arni Kristinsson
    Gordon T McInnes
    Jesper Mehlsen
    Markku Nieminen
    Eoin O’Brien
    Jan Östergren
    Drugs, 2004, 64 : 43 - 60
  • [29] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial -: Lipid lowering arm (ASCOT-LLA):: A multicentre randomised controlled trial
    Sever, PS
    Dahlöf, B
    Poulter, NR
    Wedel, H
    Beevers, G
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    DRUGS, 2004, 64 (Suppl 2) : 43 - 60
  • [30] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
    Sever, PS
    Dahlöf, B
    Poulter, NR
    Wedel, H
    Beevers, G
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    LANCET, 2003, 361 (9364): : 1149 - 1158
1234